Navellier & Associates’s Bio-Techne TECH Stock Holding History

Navellier & Associates’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12,412	Closed	-$881K	–	284
2022 Q3	$881K	Sell	12,412 -180	-1%	-$15.6K	0.2%	108
2022 Q2	$1.09M	Buy	+12,592	New	+$1.18M	0.23%	102
2022 Q1	–	Sell	-58,592	Closed	-$7.58M	–	347
2021 Q4	$7.58M	Sell	58,592 -23,776	-29%	-$2.91M	1.1%	20
2021 Q3	$9.98M	Buy	82,368 +16	+0%	+$1.95K	1.5%	9
2021 Q2	$9.27M	Buy	82,352 +128	+0.2%	+$13.5K	1.4%	12
2021 Q1	$7.85M	Buy	+82,224	New	+$7.5M	1.41%	10
2020 Q3	–	Sell	-6,964	Closed	-$460K	–	260
2020 Q2	$460K	Sell	6,964 -788	-10%	-$47.2K	0.11%	140
2020 Q1	$367K	Sell	7,752 -600	-7%	-$30K	0.09%	160
2019 Q4	$458K	Buy	8,352 +2,056	+33%	+$108K	0.07%	190
2019 Q3	$308K	Buy	+6,296	New	+$316K	0.05%	218

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Navellier & Associates's TECH Position: Q4 2022 in Review

Navellier & Associates sold out of Bio-Techne (TECH) in Q4 2022, closing a stake of 12,412 shares — an estimated $881K sold.

Navellier & Associates first reported a position in TECH in Q3 2019 and held it in 10 quarters. The position peaked at $9.98M in Q3 2021. 545 funds tracked by Wall St. Rank hold TECH as of Q4 2022.

Navellier & Associates reported no remaining Bio-Techne position as of Q4 2022 after selling out during the quarter.
Navellier & Associates sold 12,412 Bio-Techne shares in Q4 2022, an estimated $881K.
Navellier & Associates first reported a position in Bio-Techne in Q3 2019 and held it in 10 quarters.
Navellier & Associates's Bio-Techne position peaked at $9.98M in Q3 2021.
545 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2022.

Based on Navellier & Associates's 13F filing for Q4 2022, filed 2 Feb 2023.